Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1964 2
1968 2
1970 2
1974 1
1975 2
1978 1
1979 1
1982 2
1989 4
1990 2
1991 1
1992 2
1993 1
1994 2
1996 3
1997 1
1998 3
1999 1
2000 3
2001 3
2002 6
2003 7
2004 10
2005 8
2006 26
2007 21
2008 24
2009 29
2010 26
2011 53
2012 51
2013 72
2014 101
2015 91
2016 94
2017 121
2018 151
2019 174
2020 162
2021 162
2022 182
2023 168
2024 203
2025 229
2026 94

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

2,007 results

Results by year

Filters applied: . Clear all
Page 1
Molecular subtyping in urothelial carcinoma treatment.
Wu X, Sheng X. Wu X, et al. Cancer Cell. 2024 Dec 9;42(12):1993-1996. doi: 10.1016/j.ccell.2024.11.001. Cancer Cell. 2024. PMID: 39658539 Free article.
The heterogeneity of urothelial carcinoma (UC) and variable treatment responses poses significant clinical challenges. In this issue of Cancer Cell, Hamidi et al. conducted a multi-omics analysis of 2,803 UC patients from four clinical trials with anti-PD-L1, revealing fou …
The heterogeneity of urothelial carcinoma (UC) and variable treatment responses poses significant clinical challenges. In this issue of Canc …
Phase 2a Study of Baxdrostat in Primary Aldosteronism.
Turcu AF, Freeman MW, Bancos I, Ben-Shlomo A, Hamidi O, Hamrahian AH, Huang W, Kirschner LS, Sam R, Mallappa A, Tuyishimire B, Lihn AS, Perl S, Brown MJ; SPARK Investigator Group. Turcu AF, et al. N Engl J Med. 2025 Jul 31;393(5):515-518. doi: 10.1056/NEJMc2508629. Epub 2025 Jul 13. N Engl J Med. 2025. PMID: 40658651 Free article. No abstract available.
Transfeminine Hormone Therapy.
Hamidi O, Davidge-Pitts CJ. Hamidi O, et al. Endocrinol Metab Clin North Am. 2019 Jun;48(2):341-355. doi: 10.1016/j.ecl.2019.02.001. Epub 2019 Mar 23. Endocrinol Metab Clin North Am. 2019. PMID: 31027544 Review.
Building a post-myocardial infarction discharge intervention program for Hispanic patients.
Ludmir J, Suero-Abreu GA, Gonzalez de la Nuez A, Robles M, Wood MJ, Del Carmen MG, Wasfy JH. Ludmir J, et al. Healthc (Amst). 2024 Mar;12(1):100730. doi: 10.1016/j.hjdsi.2023.100730. Epub 2023 Dec 12. Healthc (Amst). 2024. PMID: 38087744
Because of the challenges Hispanic patients face with post-AMI care, the Hispanic Acute Myocardial Infarction Discharge Intervention Study (HAMIDI) was launched to provide a culturally sensitive discharge framework to improve readmission and mortality rates in this populat …
Because of the challenges Hispanic patients face with post-AMI care, the Hispanic Acute Myocardial Infarction Discharge Intervention Study ( …
Advances in Anaplastic Thyroid Cancer Treatment.
Hamidi S, Maniakas A, Cabanillas ME. Hamidi S, et al. Endocrinol Metab Clin North Am. 2025 Sep;54(3):361-375. doi: 10.1016/j.ecl.2025.03.009. Epub 2025 Jun 10. Endocrinol Metab Clin North Am. 2025. PMID: 40716892 Review.
TANK-binding kinase 1 is a mediator of platelet-induced EMT in mammary carcinoma cells.
Zhang Y, Unnithan RVM, Hamidi A, Caja L, Saupe F, Moustakas A, Cedervall J, Olsson AK. Zhang Y, et al. FASEB J. 2019 Jul;33(7):7822-7832. doi: 10.1096/fj.201801936RRR. Epub 2019 Mar 26. FASEB J. 2019. PMID: 30912981
Altogether, these results suggest that TBK1 contributes to tumor invasiveness and may be a driver of metastatic spread in breast cancer.-Zhang, Y., Unnithan, R. V. M., Hamidi, A., Caja, L., Saupe, F., Moustakas, A., Cedervall, J., Olsson, A.-K. TANK-binding kinase 1 is a m …
Altogether, these results suggest that TBK1 contributes to tumor invasiveness and may be a driver of metastatic spread in breast cancer.-Zha …
Role of CD14 in human disease.
Sharygin D, Koniaris LG, Wells C, Zimmers TA, Hamidi T. Sharygin D, et al. Immunology. 2023 Jul;169(3):260-270. doi: 10.1111/imm.13634. Epub 2023 Mar 27. Immunology. 2023. PMID: 36840585 Free PMC article. Review.
MicroRNA-217: a therapeutic and diagnostic tumor marker.
Hamidi AA, Zangoue M, Kashani D, Zangouei AS, Rahimi HR, Abbaszadegan MR, Moghbeli M. Hamidi AA, et al. Expert Rev Mol Diagn. 2022 Jan;22(1):61-76. doi: 10.1080/14737159.2022.2017284. Epub 2021 Dec 23. Expert Rev Mol Diagn. 2022. PMID: 34883033 Review.
2,007 results